AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Docetaxel improves survival and reduces risk of relapse.(breast cancer treatment)(Brief Article)

Women's Health Weekly

| June 13, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JUN 13 - (NewsRx.com & NewsRx.net) -- Women with early stage breast cancer treated with a docetaxel-based regimen after surgery had 32% less chance of their cancer returning than women receiving one of the most effective adjuvant - or postsurgery - treatments available.

Results from BCIRG 001, the first phase III study evaluating docetaxel after breast surgery, were presented at the American Society of Clinical Oncology (ASCO) meeting by the Breast Cancer International Research Group (BCIRG).

In the analysis of the study, women were divided into two groups, those with one to three positive lymph nodes and those with four or more. The most significant benefit from the use of docetaxel was seen in women with one to three positive lymph nodes. Among these women, treatment with docetaxel reduced the risk of relapse by 50% and reduced the mortality rate by 54%. Women with one to three positive lymph nodes make up 60-70% of all women worldwide with node-positive early stage breast cancer.

"The superior results observed with the docetaxel-based regimen indicate that it can potentially cure more women than one of the best chemotherapies we have," said Jean-Marc Nabholtz, MD, chairman of the Breast Cancer International Research Group (BCIRG), study chairman, and professor of medicine at the University of California at Los Angeles and Director of the Cancer Therapy Development Program at the Jonsson Comprehensive Cancer Center at UCLA. "Although early, these results should be considered when choosing therapy for a large number of women with early breast cancer."

The BCIRG 001 study was designed to determine if docetaxel, one of the most active agents in advanced breast cancer, would also have benefits for women with early-stage disease. Study participants received either a postsurgery regimen of docetaxel (Taxotere), doxorubicin (Adriamycin), and cyclophosphamide (Cytoxan), known as TAC, or the widely used standard regimen of 5-fluorouracil, doxorubicin and cyclophosphamide, known as FAC. BCIRG 001 ...

Related articles from newspapers, magazines, journals, and more
Breast Cancer Survivor Jaclyn Smith Urges Women to Know Their Breast Cancer...
Press release article from: PR Newswire July 10, 2007 700+ words
...Practitioners in Women's Health...National Breast Cancer Organization...to me as a woman to know about breast cancer risk factors...with other women," said...history raise a woman's overall...encourage all women to learn more about their breast ...
Breast Cancer Still a Concern for Canadian Women - Canadian Cancer Society...
News wire article from: Canadian Corporate News October 2, 2000 700+ words
...all cancer deaths. Breast cancer also affects men...cent of all cases of breast cancer. - The major risk factors are: - being a woman; - increasing age, especially women over 50; - previous breast cancer; - strong pre...
Breast Cancer Research Conference May 6-8, 2006, Montreal: Canadian and...
News wire article from: Canadian Corporate News May 1, 2006 700+ words
...Hot topics in Breast Cancer Research Saturday...and the Causes of Breast Cancer Dr. Norman Boyd...Very High Risk Woman Dr. Ellen Warner...Metastasis to Bone Breast Cancer to Bone Dr. Alexander...for High-risk Women Techniques for...
Breast Cancer Research Stamp Funding the Fight to Find a Cure for a Decade;...
News wire article from: AScribe Health News Service July 29, 2008 700+ words
...major ethnic group in this country, breast cancer is the most commonly diagnosed cancer in women, aside from skin cancer. Over...women in the U.S. are living with breast cancer, one million of whom have yet to...
Breast cancer risk and immune responses in healthy women.(Clinical report)
Magazine article from: Oncology Nursing Forum Park, Na-Jin Kang, Duck-Hee November 1, 2006 700+ words
...early identification of women at risk for breast cancer and developing appropriate...increased risk of developing breast cancer in women with a family history...detection of at-risk women and risk reduction for breast cancer. One step toward that...
Breast-cancer month begins with annual competition for dollars, cachet.
Newspaper article from: Philadelphia Inquirer (Philadelphia, PA) September 28, 2004 700+ words
...The American breast cancer movement has indeed...the late 1970s, when women who had their breasts...strike about 216,000 women and kill 40,000...saves lives, as most breast cancer organizations preach...ensured that even poor women have ready access to...
BREAST CANCER STUDY SPURS NEW SCRUTINY.(CAPITAL REGION)
Newspaper article from: Albany Times Union (Albany, NY) April 18, 1994 700+ words
...of the state's Breast Cancer Coalition said...environmental links to breast cancer. They also criticized...study found that women who lived near...chance of developing breast cancer after menopause...not study each woman's exposure to...
Breast cancer risk and DDT: no verdict yet.
Magazine article from: Science News Fackelmann, Kathy A. April 23, 1994 700+ words
...researchers studied 150 women who developed breast cancer an average of 14...points out. These women tend to have a lower risk of a breast cancer, especially if...likely to develop breast cancer after menopause than women who did not live...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA